Statistics for Northwest Biotherapeutics, (id:11182 NWBO)
Valuation metrics
Market cap
393.07M
Enterprise value
469.63M
Trailing P/E (ttm)
-4.50
Forward P/E
PEG ratio
Price/Sales (ttm)
238.95
Price/Book (mrq)
-4.29
Enterprise Value/Revenue
285.49
Enterprise Value/EBITDA
-7.77
Overview
Shares outstanding
1.25B
Float
1.14B
Shares short
14.14M
% Held by insiders
0.09%
% Held by institutions
0.00%
Average volume (10 days)
2.24M
Average volume (90 days)
Price summary
52-Week low
0.24
52-Week high
0.88
52-Week change
-162.96%
Beta
-0.56
50-Day moving average
0.30
200-Day moving average
0.42
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
September 26th, 2012
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
-3,424.31%
Operational effectiveness
Return on assets
-137.16%
Return on equity
97.87%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-60,473,000.00
Net income to common (ttm)
-75,549,000.00
Diluted EPS (ttm)
-0.07
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
2.88M
Total cash per share (mrq)
0.00
Total debt (mrq)
55.57M
Total Debt/Equity (mrq)
-0.73
Current ratio (mrq)
8.90%
Book value per share (mrq)
-0.06
Cash flow
Cash flow statement
-59,480,000.00
Levered free cash flow (LFCF)
-37,446,752.00